论文信息 - Abstract PD2-09: The genomic landscape of intrinsic and acquired resistance to cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) in patients with hormone receptor-positive (HR+)/HER2- metastatic breast cancer (MBC) - 字舞流文

Abstract PD2-09: The genomic landscape of intrinsic and acquired resistance to cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) in patients with hormone receptor-positive (HR+)/HER2- metastatic breast cancer (MBC)

E. Winer | L. Garraway | Pingping Mao | Kailey J. Kowalski | Gabriela N. Johnson | N. Wagle | S. Wander | S. Tolaney | S. Buchanan | X. Ye | V. Jansen | Dewey Kim | M. Lloyd | K. Helvie | J. Buendia-Buendia | F. Luo | U. Nayar | Chunping Yu | N. Lin | X. Gong | R. Martinez | S. Parsons | L. Litchfield | Ofir Cohen